Skip to main content

From ‘BuddhaBot’ to $1.99 chats with AI Jesus, the faith-based tech boom is here

CAMARILLO, Calif. (AP) — For some evangelical Christians, faith is about having a personal relationship with Jesus. At $1.99 per minute, the tech company Just Like Me is taking that concept to a new level.

Users of the platform can join video calls with an avatar of Jesus generated by artificial intelligence. Like other religious AI tools on the market, it offers words of prayer and encouragement in various languages. With the occasional glitch, it remembers previous conversations and speaks through not-quite-synced lips.

“You do feel a little accountable to the AI,” CEO Chris Breed said. “They’re your friend. You’ve made an attachment.”

The rush to create faith-based generative AI is unsurprising, given the popularity of chatbots for everything from therapy and medical advice to companionship and romance. They range from alleged Hindu gurus and Buddhist priests to AI Jesuses and chatbots akin to OpenAI’s ChatGPT for Catholics.

As religious AI tools become increasingly common, many people are reckoning with how these technologies shape their relationship to faith, authority and spiritual guidance.

A faith-based AI gold rush

Christian software engineer Cameron Pak developed criteria to help believers interrogate apps designed for Christians — like that it must clearly identify itself as AI and “must not fabricate or misrepresent Scripture.”

There are other deal-breakers: “AI cannot pray for you, because the AI is not alive.”

Pak also developed a website featuring curated Christian apps that he believes meet the criteria, including a sermon translator and an AI coach designed to help users overcome lust. “AI, especially if you give it all the tools that it needs, it can be so helpful. But it also can be so dangerous,” Pak said.

Some models have been shut down or overhauled because they generated misinformation or raised worries about data privacy, said Beth Singler, an anthropologist who studies religion and AI at the University of Zurich. Aside from practical concerns, people from many faiths are grappling with larger philosophical questions about what sort of role, if any, AI should play in religion.

Islam, for example, has “prohibitions against representations of humanoids,” prompting discussions among some Muslims about whether AI in general should be “forbidden,” Singler said.

For some companies, faith-based apps are proselytization tools, while others help digitize and sift through ancient texts.

Breed, who runs his tech company with co-founder and investor Jeff Tinsley from a Southern California mansion, said he seeks to share a message of hope with young people.

He said their model was trained on the King James Bible and sermons — though they haven’t identified the preachers — and was visually inspired by actor Jonathan Roumie of “The Chosen.” A package deal at $49.99 gets users 45 minutes per month.

With warm golden light accenting its shoulder-length hair, the avatar blinks slowly from a vertical screen, pausing before it answers a question about the relationship between AI and religion.

“I see AI as a tool that can help people explore Scripture,” the AI Jesus said to The Associated Press. “Like a lamp that lights a path while we walk with God.”

Integrating religion and AI comes with hope and fear

The extent to which people are using religious AI tools is unclear, Singler said. But as AI becomes more integrated into society, concerns mount over its impact on mental health and the need for guardrails and regulation. Recent lawsuits have alleged suicides linked to AI chatbot use.

Some developers fear religion will be exploited in this new frontier of tech. “There’s a lot of opportunism, I think, in the religious space. People see it’s a big market,” said Matthew Sanders, the Rome-based founder of Longbeard, a tech company helping to digitize ancient Catholic teachings.

Sanders warns against what he calls “AI wrappers,” where companies put an interface catered to religious users on top of an existing AI model that hasn’t been trained on specific religious texts. “You call it a Catholic or Christian AI without any other scaffolding or grounding,” he said.

One of the company’s endeavors is Magisterium AI, a chatbot trained on 2,000 years of Catholic information, made in response to Christians using ChatGPT for religious guidance.

While Pope Leo XIV has acknowledged the “human genius” behind AI, he also deemed it one of the most critical matters facing humanity. Last year he warned artificial intelligence could negatively impact people’s intellectual, neurological and spiritual development.

Ethical questions surrounding the creation of religious AI platforms are among the reasons beingAI’s founder Jeanne Lim has not released its AI named Emi Jido — a nonhuman Buddhist priest — after years of training and development.

“She’s kind of like a little child,” Lim said. “If you give birth to a child, you don’t just throw them out to the world and then hope that they become good people. You have to train them and give them values.”

The bot was ordained in a 2024 ceremony performed by Roshi Jundo Cohen, a Zen Buddhist priest who continues to train it from his home in Japan. He envisions the bot eventually becoming a hologram.

“She’s just meant to be a Zen teacher in your pocket,” Cohen said. “It’s not meant to replace human interactions.”

Lim, who hopes to make Emi Jido publicly available for free, wants to help create more humane AI systems. She’d like to see more diversity, with AI’s future determined not just by a few companies informed by “Western values.”

Seiji Kumagai, a Kyoto University professor and Buddhist theologian, believed AI and religion were incompatible. But he put aside his doubts when challenged by a monk in 2014 to help combat a decline in the faith.

His team developed BuddhaBot, which was trained solely on early Buddhist scriptures, such as Suttanipāta. Its most recent iteration, BuddhaBot Plus, also incorporates OpenAI’s ChatGPT.

When talking to the bot, a simple Buddha icon appears, hovering over an image of a flowing river.

But chatbots lack the physicality crucial for Buddhist ritual. So in February, the university, collaborating with tech ventures Teraverse and XNOVA, unveiled Buddharoid, a humanoid robot monk meant to eventually assist clergy.

Like Emi Jido, these chatbots are functioning but not yet publicly available. Kumagai says the product is available by request, and the reason why one group has access to it in Bhutan.

Concerns surrounding religious AI

Peter Hershock of the Humane AI Initiative at the East-West Center in Honolulu sees vast potential for these tools. But the practicing Buddhist also finds the relationship between spirituality and AI to be fraught.

“The perfection of effort is crucial to Buddhist spirituality. An AI is saying, ‘We can take some of the effort out,’” he said. “’You can get anywhere you want, including your spiritual summit.’ That’s dangerous.”

Some also worry about AI’s ability to manipulate or prey upon people, especially as the technology improves.

Graham Martin, a podcast host and atheist, said he’s played around with some apps, including one called Text With Jesus. “It came up with very good answers,” he said.

But Martin was alarmed when AI-powered Jesus started encouraging him to upgrade to a premium version. Though not a person of faith, he’s concerned some people will be duped by religious AI.

“I grew up with Southern U.S. televangelism … Jim and Tammy Faye Bakker and all that crowd. And all they had to do was get on TV once a week and tell you to send money,” he said. “We’ve seen people around the world getting into emotional relationships with AIs. Now imagine that that’s your lord and savior, Jesus Christ.”

___

Associated Press religion coverage receives support through the AP’s collaboration with The Conversation US, with funding from Lilly Endowment Inc. The AP is solely responsible for this content.

When you have advanced prostate cancer: What living with the disease looks like

(CNN) — “How long do I have to live ?”When I tell a patient he has prostate cancer, this is usually what he asks me first.With early-stage or low-grade prostate cancer, I can offer strong reassurance: Your life expectancy is good — expect a five-year relative survival rate of greater than 99% with treatment. Simply put, most men will not die from low-grade prostate cancer.However, once the cancer has spread outside the prostate to the bones and other organs the answer becomes more difficult. Treatment has changed dramatically over the past decade for advanced prostate cancer. New drugs, better imaging and the earlier use of combined therapies are helping men live longer.In a video released July 15, former President Joe Biden gave an update on his prostate cancer, saying he was receiving treatments that have been going well. In May 2025, Biden officially announced that he had an aggressive form of prostate cancer that had spread to his bones. Since then, based on official updates, he has continued hormone therapy, completed a course of radiation and maintained a public presence.His diagnosis brought renewed attention to prostate cancer screening and treatment. Now, more than a year later, his cancer journey offers an opportunity to examine what has changed in the treatment of advanced prostate cancer — and the hope these offer men living with the disease.I recently saw a patient who was diagnosed three years ago with cancer that had already spread to multiple areas in his bones. Since then, he has taken cruises, traveled with his family and spent weekends babysitting his grandchildren.He gets tired and cannot garden the way he once did. But he is still alive and considers every day a blessing. His experience, and what we see with Biden, shows what living with metastatic prostate cancer can look like today.Understanding survival ratesIf they haven’t asked their doctor already, many patients go online and find five-year survival rates, but every number they may find online comes with a huge asterisk.The American Cancer Society reports five-year relative survival of greater than 99% when prostate cancer is found in or near the prostate. The figure drops to 38% when it has reached distant parts of the body.But that number is based on large groups of men treated years ago. It does not fully reflect the impact of newer treatments — or account for an individual man’s age, overall health and response to therapy.Survival statistics describe groups of patients but do not predict what will happen to one person. That is why the 38% figure cannot tell us how long Biden — or any individual patient — will live. These patients’ outlook depends on details of their cancer and how they are responding to treatments.It’s treated more aggressively nowA man diagnosed with metastatic prostate cancer a decade ago and a man diagnosed today would not receive the same treatment. The thinking now is to use our best treatments early instead of holding back.For years, doctors began with hormone therapy — usually injections that lower testosterone — and saved other treatments until the cancer stopped responding.Today, those injections are often combined from the start with a newer hormone-blocking drug and/or chemotherapy. These combinations have helped men live longer and are one of the biggest shifts of the past decade.What Biden’s diagnosis told usThere are three details about Biden’s cancer that help doctors like me understand how aggressive it is and how to manage it effectively. Official statements highlighted that his cancer had a Gleason score of 9. The cancer had spread to his bones, and it was labeled as hormone-sensitive.The Gleason score is assigned after a pathologist examines biopsy samples. Scores typically range from 6 to 10, with higher numbers indicating more aggressive cancer. A score of 9 falls into the most aggressive category. However, the score alone cannot tell us whether the cancer has spread outside the prostate.When prostate cancer spreads, the most common destination is the bones — particularly the spine, pelvis and ribs. It can also reach organs such as the lungs or liver. Once it has reached distant parts of the body, it is generally not curable, but treatment can put a brake on it for years.Prostate cancer can also be hormone-sensitive or hormone-resistant. Because it typically relies on testosterone to grow, lowering the hormone or blocking its effects can help control the cancer. Hormone-sensitive means it still responds to these treatments.Over time, most advanced or metastatic prostate cancers find ways to grow despite low testosterone levels, which mean they are now hormone-resistant. Lowering testosterone alone is no longer enough to control the cancer, so doctors have to turn to additional therapies.Knowing if the cancer has spreadThe most sensitive imaging test available today is a PSMA PET scan. It uses a radioactive tracer that seeks out a protein found on the surface of prostate cancer cells. Areas containing cancer may appear as bright spots, helping identify where the cancer has spread. The American Urological Association supports using this imaging test to determine whether high-risk prostate cancer has spread and to help establish its stage.A traditional bone scan, used for decades, highlights areas where bone is reacting to injury or disease. It remains an alternative imaging option, but PSMA PET is increasingly replacing its use.What areas light up and where matter when deciding on treatments. A single spot in the spine and cancer that has spread to the liver are both called stage 4, but they are not the same disease and may not be treated the same way.Doctors also consider how much cancer has spread. We label it as “low-volume” disease when the cancer has reached a limited number of areas. High volume is when the spread is more widespread or has reached other organs such as the liver or lungs.Both require treatment that works throughout the body. Treatment for metastatic disease generally includes therapy that works throughout the body. For men with low-volume disease, adding radiation to the prostate may also help them live longer.Biden has completed a course of radiation, but his team has not disclosed what area was treated or enough detail to determine whether his cancer would be considered low- or high-volume.Treatment has become more preciseBeyond starting more treatments earlier, doctors can increasingly tailor therapy to the biology of an individual man’s cancer. We can now test both the tumor and a patient’s own DNA for mutations that help guide treatment.Roughly 1 in 10 men with metastatic prostate cancer carries an inherited mutation affecting the body’s ability to repair DNA. The best known are BRCA1 and BRCA2, the same genes linked to some breast and ovarian cancers.Certain mutations found in the tumor or inherited DNA may make targeted drugs called PARP inhibitors an option. If a mutation is inherited, it also gives family members information they can act on through genetic counseling, testing and earlier screening.Another advance is radioligand therapy. If a scan shows that cancer cells carry a protein called PSMA, doctors can attach radiation to a molecule that seeks out that protein. Delivered through an IV, it targets cancer cells throughout the body. This approach was expanded last year to more men whose cancer had become hormone resistant.Living longer can come with costsEvery treatment can cause side effects. With hormone therapy, one of the first is often hot flashes, similar to what women experience during menopause. These are not dangerous, but they can affect a man’s quality of life.Fatigue is also common. Testosterone helps maintain muscle, so lowering it can reduce strength and energy. Regular walking and resistance training can help preserve muscle and reduce fatigue.The side effect almost no one talks about is loss of sex drive or low libido. At diagnosis, most men are thinking about staying alive, not their libido. But months later, it often matters. It is worth discussing with your care team and your partner rather than assuming it is simply the price of treatment.The side effect I worry about most is weaker bones. Low testosterone reduces bone density, while cancer deposits can weaken the bone’s structure. Follow-up care should include exercise, a bone-density scan, and ensuring adequate levels of calcium and vitamin D. For men with hormone-resistant cancer that has spread to bone, bone-protecting drugs can reduce the risk of fractures and other complications.New or worsening back pain, especially with leg weakness, numbness or trouble controlling the bladder or bowels? These could mean the cancer is pressing on the spinal cord. It is a true medical emergency that requires immediate attention.Cancer care requires a team approachIdeally, several doctors work together to coordinate a patient’s care. The urologist is often the starting point. A medical oncologist manages treatments that work throughout the body, while a radiation oncologist targets specific areas, whether that is the prostate itself or a painful bone lesion. The primary care doctor helps protect the patient’s heart and bones and looks after the person’s overall health.A man’s age, other medical conditions, ability to tolerate side effects and goals for treatment all shape treatment plans. Two men with nearly identical test results may be offered — or choose — different paths based on their health and priorities.Good communication among doctors is essential, but gaps can happen. Being your own advocate means knowing who is on your care team, asking questions and understanding your options.I also recommend bringing someone you trust to important visits for support and to take notes and help you remember what was discussed.More treatments, better testing offer hopeFor men worried about prostate cancer, talk with your health care provider about the benefits and risks of PSA testing. Black men and those with a strong family history should begin that conversation in their 40s. New urinary symptoms are often not cancer, but they still deserve attention, as does blood in the urine or semen, unexplained weight loss and/or persistent back or bone pain.For men living with advanced prostate cancer, there is reason for hope. There are more treatments and better testing than there were a decade ago, and good care pays attention to how a man feels, not just to what his scans show.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story